» Articles » PMID: 35163268

An Overview of Epigenetics in Obesity: The Role of Lifestyle and Therapeutic Interventions

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163268
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity has become a global epidemic that has a negative impact on population health and the economy of nations. Genetic predispositions have been demonstrated to have a substantial role in the unbalanced energy metabolism seen in obesity. However, these genetic variations cannot entirely explain the massive growth in obesity over the last few decades. Accumulating evidence suggests that modern lifestyle characteristics such as the intake of energy-dense foods, adopting sedentary behavior, or exposure to environmental factors such as industrial endocrine disruptors all contribute to the rising obesity epidemic. Recent advances in the study of DNA and its alterations have considerably increased our understanding of the function of epigenetics in regulating energy metabolism and expenditure in obesity and metabolic diseases. These epigenetic modifications influence how DNA is transcribed without altering its sequence. They are dynamic, reflecting the interplay between the body and its surroundings. Notably, these epigenetic changes are reversible, making them appealing targets for therapeutic and corrective interventions. In this review, I discuss how these epigenetic modifications contribute to the disordered energy metabolism in obesity and to what degree lifestyle and weight reduction strategies and pharmacological drugs can restore energy balance by restoring normal epigenetic profiles.

Citing Articles

Investigation of calonysterone and 20-hydroxyecdysone effects in high-fat, high-sugar diet-induced obesity rat model.

Osman A, Laczko D, Vagvolgyi M, Seres-Bokor A, Sztojkov-Ivanov A, Kemeny K Heliyon. 2025; 11(3):e42435.

PMID: 39991217 PMC: 11847253. DOI: 10.1016/j.heliyon.2025.e42435.


Association of Fat Mass and Obesity (FTO) rs9939609 Single Nucleotide Polymorphism (SNP) With Obesity and Type 2 Diabetes (T2D) in Healthy Young Adults in Kuwait.

Jamali M, Abdeen S, Mathew T Cureus. 2025; 17(1):e77110.

PMID: 39925495 PMC: 11802477. DOI: 10.7759/cureus.77110.


Epigenetic Regulation of Innate and Adaptive Immune Cells in Salt-Sensitive Hypertension.

Mutchler A, Porcia Haynes A, Saleem M, Jamison S, Khan M, Ertuglu L Circ Res. 2025; 136(2):232-254.

PMID: 39819017 PMC: 11750173. DOI: 10.1161/CIRCRESAHA.124.325439.


High-Fat Diet, Epigenetics, and Atherosclerosis: A Narrative Review.

Rai V Nutrients. 2025; 17(1.

PMID: 39796562 PMC: 11722563. DOI: 10.3390/nu17010127.


Effect of Long-Term Taurine Supplementation on the Lipid and Glycaemic Profile in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.

Sun Q, Wang J, Wang H, Yu H, Wan K, Ma F Nutrients. 2025; 17(1.

PMID: 39796489 PMC: 11722866. DOI: 10.3390/nu17010055.


References
1.
Piyathilake C, Badiga S, Kabagambe E, Azuero A, Alvarez R, Johanning G . A dietary pattern associated with LINE-1 methylation alters the risk of developing cervical intraepithelial neoplasia. Cancer Prev Res (Phila). 2012; 5(3):385-92. PMC: 5547882. DOI: 10.1158/1940-6207.CAPR-11-0387. View

2.
Cooper C, Neufeld E, Dolezal B, Martin J . Sleep deprivation and obesity in adults: a brief narrative review. BMJ Open Sport Exerc Med. 2018; 4(1):e000392. PMC: 6196958. DOI: 10.1136/bmjsem-2018-000392. View

3.
Denham J, Marques F, Bruns E, OBrien B, Charchar F . Epigenetic changes in leukocytes after 8 weeks of resistance exercise training. Eur J Appl Physiol. 2016; 116(6):1245-53. DOI: 10.1007/s00421-016-3382-2. View

4.
Heijmans B, Tobi E, Stein A, Putter H, Blauw G, Susser E . Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A. 2008; 105(44):17046-9. PMC: 2579375. DOI: 10.1073/pnas.0806560105. View

5.
Day S, Garcia L, Coletta R, Campbell L, Benjamin T, De Filippis E . Alterations of sorbin and SH3 domain containing 3 (SORBS3) in human skeletal muscle following Roux-en-Y gastric bypass surgery. Clin Epigenetics. 2017; 9:96. PMC: 5581422. DOI: 10.1186/s13148-017-0396-5. View